Barinthus Biotherapeutics plc (BRNS) Misses Q2 EPS by 16c
Tweet
Share
E-mailGet Alerts BRNS Hot Sheet
Join SI Premium – FREE
Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q2 EPS of ($0.52), $0.16 worse than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abu Dhabi's G42 Weighs US Ownership To Safeguard AI Chip Access - Bloomberg
- UBS Reiterates Buy Rating on PVH Corp (PVH) on Strong Earnings Growth Potential
- Geiger Energy director James Sykes resigns from board
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
